Table 1_Cost comparison of minimally invasive transforaminal lumbar interbody fusion: experience from Nigeria and the United States.pdf

Due to prohibitive costs, neither surgical approach is readily accessible in developing countries. Objectives—to report our experience with minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in Nigeria, a lower-middle-income country, and to compare it with data from our prior practice in the United States (U. S.).</p>Methods<p>An observational, comparative analysis was conducted between two retrospective cohorts of MIS-TLIF patients in Nigeria and the U. S. Demographic data, perioperative parameters (SDn, estimated blood loss [EBL], and LOS), perioperative surgical site complications, and patient-reported outcomes (Numeric Rating Scale [NRS] and Oswestry Disability Index [ODI]) for patients who underwent MIS-TLIF for degenerative spine disease from June 2018 to May 2022 in the Nigerian practice were retrieved from the database.

Minimal clinically important differences (MCID) in patient-reported outcomes (PROs) were defined as a two-point change on the NRS and a 5.9–20-point difference on the ODI. The hospital’s accounts section provided the direct costs, which were converted from Nigerian Naira to U. S. dollars. Data from both cohorts, which had similar surgical indications, the same lead surgeon, and similar operative techniques and perioperative management, were compared.</p>Results<p>The median age of the 65 patients was 61 years; 37 were female.